Vitalab Co Inc Recall: The firm's vitamin C dietary supplement contains lactose, a milk-derived ingredient, but fails to declare the major food allergen "milk" on the label. - F-0883-2018
United States
TerminatedClass II
- Company
- Vitalab Co Inc
- Product
- Product packaged in the following ways A) Sonne's, No. 17, N…
- Recall date
- February 8, 2018
- Terminated
- July 24, 2018
- Source
- FDA
Reason for recall
The firm's vitamin C dietary supplement contains lactose, a milk-derived ingredient, but fails to declare the major food allergen "milk" on the label.
- - Recall initiated
- - Reported by source
- - Recall terminated
| Product description | UPC | Quantity | Lot / code information |
|---|---|---|---|
| Product packaged in the following ways A) Sonne's, No. 17, Natural Source Vitamin C, Dietary Supplement, (920 mg tablet wt.) Contents - 120 Tablets, National Distributors: Sonne's Organic Foods, Inc. N. Kansas City, MO 64116; B) Springreen, No. 87, Natural Source Vitamin C, Dietary Supplement, (920 mg tablet wt.) Contents - 120 Tablets, National Distributors: Springreen Products, Inc. N. Kansas City, MO 64116; | Not published in this source record | 1,703 bottles | Lot #s: 12-1-18-1, 02-20-19-1, 02-27-19-2, 06-26-19-3, 08-07-19-4 |
Distribution
- Product distributed to consumers
- distributors and retailers in the following US states AZ
- CA
- CO
- FL
- GA
- IA
- IL
- IN
- KS
- KY
- MA
- MD
- MI
- MN
- MO
- NE
- NJ
- NY
- OH
- OR
- PA
- SD
- TN
- TX
- UT
- VA
- VT
- WA
- WI and Canada.
Official source record
- Agency
- FDA
- Dataset
- FDA Food Enforcement (Recalls)
- Recall number
- F-0883-2018
- Event ID
- 79113
- Status
- Terminated
- Classification
- Class II
- Company
- Vitalab Co Inc
- Product description
- Product packaged in the following ways A) Sonne's, No. 17, Natural Source Vitamin C, Dietary Supplement, (920 mg tablet wt.) Contents - 120 Tablets, National Distributors: Sonne's Organic Foods, Inc. N. Kansas City, MO 64116; B) Springreen, No. 87, Natural Source Vitamin C, Dietary Supplement, (920 mg tablet wt.) Contents - 120 Tablets, National Distributors: Springreen Products, Inc. N. Kansas City, MO 64116;
- Quantity
- 1,703 bottles
- Reason
- The firm's vitamin C dietary supplement contains lactose, a milk-derived ingredient, but fails to declare the major food allergen "milk" on the label.
- Recall initiation date
- February 8, 2018
- Report date
- March 14, 2018
- Classification date
- Not published in this source record
- Termination date
- July 24, 2018
- Distribution pattern
- Product distributed to consumers, distributors and retailers in the following US states AZ, CA, CO, FL, GA, IA, IL, IN, KS, KY, MA, MD, MI, MN, MO, NE, NJ, NY, OH, OR, PA, SD, TN, TX, UT, VA, VT, WA, WI and Canada.
- UPC, lot, and code information
- Lot #s: 12-1-18-1, 02-20-19-1, 02-27-19-2, 06-26-19-3, 08-07-19-4
- Voluntary or mandated
- Voluntary: Firm initiated
- Initial notification method
- Letter
- Source last updated
- Not tracked separately from the Public Health Trace retrieval date below
- Public Health Trace retrieval date
Responsible company: Vitalab Co Inc
A map highlighting the states named in the source's distribution description.
Shading reflects state-level totals only, as published by the source. It does not imply county-level or point-level precision.
| State | Distributed |
|---|---|
| Arizona | 1 |
| California | 1 |
| Colorado | 1 |
| Florida | 1 |
| Georgia | 1 |
| Iowa | 1 |
| Illinois | 1 |
| Indiana | 1 |
| Kansas | 1 |
| Kentucky | 1 |
| Massachusetts | 1 |
| Maryland | 1 |
| Michigan | 1 |
| Minnesota | 1 |
| Missouri | 1 |
| Nebraska | 1 |
| New Jersey | 1 |
| New York | 1 |
| Ohio | 1 |
| Oregon | 1 |
| Pennsylvania | 1 |
| South Dakota | 1 |
| Tennessee | 1 |
| Texas | 1 |
| Utah | 1 |
| Virginia | 1 |
| Vermont | 1 |
| Washington | 1 |
| Wisconsin | 1 |
States shown are extracted from the source's free-text distribution description above; a narrative description (e.g. "distributed nationwide") may not list individual states to extract.
Where this information comes from
View FDA enforcement record -- the specific openFDA record this summary was built from.
This record comes from FDA's Enforcement Report database. Not every Enforcement Report record has a separate FDA.gov recall-announcement page.
FDA Enforcement Reports -- FDA's general, official recall and enforcement information. See FDA Enforcement Reports versus recall announcements for how that database differs from a press-release-style announcement.
New to reading a recall record? See how to read an FDA recall record and what recall statuses mean.
Technical source data
View raw source data -- the machine-readable record this page's information was built from.
Retrieved by Public Health Trace:
Frequently asked questions
What does a Class II mean?
FDA classifies this recall as Class II. See how to read an FDA recall record (linked above) for what each classification level means.
Is this recall still active?
According to FDA, this recall's status is "Terminated." Always confirm the current status using the source links below, since status can change after Public Health Trace last retrieved this record.
What should I do if I have this product?
Follow the responsible agency's published instructions, linked below -- recall guidance is set by that agency, not by Public Health Trace.
Official guidance and record verification
Public Health Trace does not provide medical advice -- review the linked official source below for current, authoritative information.
How to interpret this historical record
This record is preserved as published by FDA, as of July 24, 2018.
Status as reported: Terminated.
This page does not imply a current danger or a current consumer instruction -- review the official source for the most current information.
This summary is based on the official source record referenced above. Public Health Trace does not state that any company or product is unsafe beyond what the official source has published. Read the full medical disclaimer.